IBDEI1AR ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22052,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,22052,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,22052,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,22053,0)
 ;;=E89.6^^87^973^47
 ;;^UTILITY(U,$J,358.3,22053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22053,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,22053,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,22053,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,22054,0)
 ;;=L68.0^^87^973^25
 ;;^UTILITY(U,$J,358.3,22054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22054,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,22054,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,22054,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,22055,0)
 ;;=M80.00XA^^87^973^2
 ;;^UTILITY(U,$J,358.3,22055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22055,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,22055,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,22055,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,22056,0)
 ;;=M81.0^^87^973^3
 ;;^UTILITY(U,$J,358.3,22056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22056,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,22056,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,22056,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,22057,0)
 ;;=M85.80^^87^973^44
 ;;^UTILITY(U,$J,358.3,22057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22057,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,22057,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,22057,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,22058,0)
 ;;=N62.^^87^973^24
 ;;^UTILITY(U,$J,358.3,22058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22058,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,22058,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,22058,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,22059,0)
 ;;=E10.43^^87^973^6
 ;;^UTILITY(U,$J,358.3,22059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22059,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,22059,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,22059,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,22060,0)
 ;;=E10.59^^87^973^4
 ;;^UTILITY(U,$J,358.3,22060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22060,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,22060,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,22060,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,22061,0)
 ;;=E10.618^^87^973^5
 ;;^UTILITY(U,$J,358.3,22061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22061,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,22061,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,22061,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,22062,0)
 ;;=E10.621^^87^973^7
 ;;^UTILITY(U,$J,358.3,22062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22062,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,22062,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,22062,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,22063,0)
 ;;=E10.622^^87^973^11
 ;;^UTILITY(U,$J,358.3,22063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22063,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,22063,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,22063,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,22064,0)
 ;;=E10.65^^87^973^10
 ;;^UTILITY(U,$J,358.3,22064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22064,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
 ;;^UTILITY(U,$J,358.3,22064,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,22064,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,22065,0)
 ;;=E10.39^^87^973^9
 ;;^UTILITY(U,$J,358.3,22065,1,0)
 ;;=^358.31IA^4^2
